Sirolimus for the Management of Verrucous Venous Malformation: A Case Report and Literature Review

Ibrahim Al-Furaih; Alanoud Al-Marzoug; Nada Al-Qadri; Saad Al-Ajlan

doi:10.1159/000515984

Sirolimus for the Management of Verrucous Venous Malformation: A Case Report and Literature Review

Case Rep Dermatol. 2021 Jun 17;13(2):298-303. doi: 10.1159/000515984. eCollection 2021 May-Aug.

Authors

Ibrahim Al-Furaih¹, Alanoud Al-Marzoug², Nada Al-Qadri³, Saad Al-Ajlan⁴

Affiliations

¹ Department of dermatology, King Fahad Medical City, Riyadh, Saudi Arabia.
² Department of dermatology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
³ Primary health care department, Ministry of Health, Riyadh, Saudi Arabia.
⁴ Department of dermatology, Alfaisal University, King Faisal Specialist Hospital & Research, Riyadh, Saudi Arabia.

Abstract

Verrucous venous malformation (VVM) is a vascular malformation that is rarely reported in the literature which has vascular and hyperkeratotic components affecting mainly the extremities, difficult to treat, and often associated with complications mainly bleeding, ulceration with secondary infections, and limitation of movement. In this article, we report a successful improvement of VVM with sirolimus.

Keywords: Case report; Sirolimus; Verrucous hemangioma; Verrucous venous malformation.

Publication types

Case Reports